RE:RE:RE:RE:Not surprisingQuote:"If they aren't being 'forced' to stop this by safety then I see no great harm in running this another few months to see what the full cohort tells you. It just sounds like a big decision to stop the trial and a relative small reason and solution. "
I disagree with this assessment. We always know that Thera management is very, very conservative and risk adverse. IMO, I think they made this move to err on the safe side.
The amended trial protocol likely will try to take into account existing data gathered in Phase 1a/b which will save time and efforts.